{"id":"https://openalex.org/W3003135182","doi":"https://doi.org/10.1016/j.ijid.2020.01.035","title":"Efficacy and safety of the regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate in fixed-dose single-tablet regimens for initial treatment of HIV-1 infection: A meta-analysis of randomized controlled trials","display_name":"Efficacy and safety of the regimens containing tenofovir alafenamide versus tenofovir disoproxil fumarate in fixed-dose single-tablet regimens for initial treatment of HIV-1 infection: A meta-analysis of randomized controlled trials","alternate_titles":[],"publication_year":2020,"publication_date":"2020-01-24","ids":{"openalex":"https://openalex.org/W3003135182","doi":"https://doi.org/10.1016/j.ijid.2020.01.035","mag":"3003135182","pmid":"https://pubmed.ncbi.nlm.nih.gov/31988012"},"language":"en","primary_location":{"id":"doi:10.1016/j.ijid.2020.01.035","doi":"https://doi.org/10.1016/j.ijid.2020.01.035","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijid.2020.01.035","pdf_url":"http://www.ijidonline.com/article/S1201971220300370/pdf","source":{"id":"https://openalex.org/S35071406","display_name":"International Journal of Infectious Diseases","issn_l":"1201-9712","issn":["1201-9712","1878-3511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3003135182"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.ijidonline.com/article/S1201971220300370/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010225402","display_name":"Xingbao Tao","orcid":"https://orcid.org/0000-0001-5533-5877","observed_orcids":["https://orcid.org/0000-0001-5533-5877"]},"institutions":[{"id":"https://openalex.org/I4210153612","display_name":"Chongqing Public Health Medical Center","ror":"https://ror.org/04dcmpg83","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153612"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xingbao Tao","raw_affiliation_strings":["National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing, 400036, China; Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China","Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China","National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing, 400036, China"],"raw_orcid":"https://orcid.org/0000-0001-5533-5877","affiliations":[{"raw_affiliation_string":"National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing, 400036, China; Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China","institution_ids":["https://openalex.org/I4210153612"]},{"raw_affiliation_string":"Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China","institution_ids":["https://openalex.org/I4210153612"]},{"raw_affiliation_string":"National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing, 400036, China","institution_ids":["https://openalex.org/I4210153612"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051846792","display_name":"Yanqiu Lu","orcid":"https://orcid.org/0000-0002-0342-4381","observed_orcids":["https://orcid.org/0000-0002-0342-4381"]},"institutions":[{"id":"https://openalex.org/I4210153612","display_name":"Chongqing Public Health Medical Center","ror":"https://ror.org/04dcmpg83","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153612"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yanqiu Lu","raw_affiliation_strings":["Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China","institution_ids":["https://openalex.org/I4210153612"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047256462","display_name":"Yihong Zhou","orcid":"https://orcid.org/0000-0002-3101-5550","observed_orcids":["https://orcid.org/0000-0002-3101-5550"]},"institutions":[{"id":"https://openalex.org/I4210153612","display_name":"Chongqing Public Health Medical Center","ror":"https://ror.org/04dcmpg83","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153612"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yihong Zhou","raw_affiliation_strings":["Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China","institution_ids":["https://openalex.org/I4210153612"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032440591","display_name":"Zhang Lvlang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153612","display_name":"Chongqing Public Health Medical Center","ror":"https://ror.org/04dcmpg83","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153612"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lvlang Zhang","raw_affiliation_strings":["Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China","institution_ids":["https://openalex.org/I4210153612"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061151592","display_name":"Yaokai Chen","orcid":"https://orcid.org/0000-0002-3229-0108","observed_orcids":["https://orcid.org/0000-0002-3229-0108"]},"institutions":[{"id":"https://openalex.org/I4210153612","display_name":"Chongqing Public Health Medical Center","ror":"https://ror.org/04dcmpg83","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153612"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yaokai Chen","raw_affiliation_strings":["National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing, 400036, China; Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China. Electronic address: yaokaichen@hotmail.com","Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China","National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing, 400036, China"],"raw_orcid":"https://orcid.org/0000-0002-3229-0108","affiliations":[{"raw_affiliation_string":"National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing, 400036, China; Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China. Electronic address: yaokaichen@hotmail.com","institution_ids":["https://openalex.org/I4210153612"]},{"raw_affiliation_string":"Department of Infection Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China","institution_ids":["https://openalex.org/I4210153612"]},{"raw_affiliation_string":"National Key Laboratory for Infectious Diseases Prevention and Treatment with Traditional Chinese Medicine, Chongqing Public Health Medical Center, Chongqing, 400036, China","institution_ids":["https://openalex.org/I4210153612"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5061151592"],"corresponding_institution_ids":["https://openalex.org/I4210153612"],"apc_list":{"value":1750,"currency":"USD","value_usd":1750},"apc_paid":{"value":1750,"currency":"USD","value_usd":1750},"fwci":0.4473,"has_fulltext":true,"cited_by_count":72,"citation_normalized_percentile":{"value":0.59675352,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"93","issue":null,"first_page":"108","last_page":"117"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":1.0},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.9580000042915344},{"id":"https://openalex.org/keywords/initial-antiretroviral-therapy","display_name":"initial antiretroviral therapy","score":0.8790000081062317},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.753000020980835},{"id":"https://openalex.org/keywords/bone-toxicity","display_name":"bone toxicity","score":0.8730000257492065},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.8169999718666077},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.9279999732971191},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.9810000061988831},{"id":"https://openalex.org/keywords/antiretroviral-naive-patients","display_name":"antiretroviral-naive patients","score":0.8669999837875366}],"concepts":[{"id":"https://openalex.org/C2911190787","wikidata":"https://www.wikidata.org/wiki/Q22075912","display_name":"Tenofovir alafenamide","level":5,"score":0.9437624216079712},{"id":"https://openalex.org/C2779344132","wikidata":"https://www.wikidata.org/wiki/Q155954","display_name":"Tenofovir","level":3,"score":0.7826048731803894},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6755167245864868},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6156582832336426},{"id":"https://openalex.org/C2776623344","wikidata":"https://www.wikidata.org/wiki/Q5456317","display_name":"Fixed-dose combination","level":2,"score":0.6074173450469971},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5531748533248901},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4916751980781555},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.42530545592308044},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3753669857978821},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2547151446342468},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.15646392107009888},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.14936068654060364}],"mesh":[{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000409","descriptor_name":"Alanine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006679","descriptor_name":"HIV Seropositivity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.ijid.2020.01.035","doi":"https://doi.org/10.1016/j.ijid.2020.01.035","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijid.2020.01.035","pdf_url":"http://www.ijidonline.com/article/S1201971220300370/pdf","source":{"id":"https://openalex.org/S35071406","display_name":"International Journal of Infectious Diseases","issn_l":"1201-9712","issn":["1201-9712","1878-3511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:31988012","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31988012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:e83dd8643aed4844ae482b3fd1b72c94","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/e83dd8643aed4844ae482b3fd1b72c94","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Infectious Diseases, Vol 93, Iss , Pp 108-117 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.ijid.2020.01.035","doi":"https://doi.org/10.1016/j.ijid.2020.01.035","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ijid.2020.01.035","pdf_url":"http://www.ijidonline.com/article/S1201971220300370/pdf","source":{"id":"https://openalex.org/S35071406","display_name":"International Journal of Infectious Diseases","issn_l":"1201-9712","issn":["1201-9712","1878-3511"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320317427","display_name":"Chongqing Municipal Health and Family Planning Commission","ror":"https://ror.org/04ce5fg13"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3003135182.pdf","grobid_xml":"https://content.openalex.org/works/W3003135182.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1872355166","https://openalex.org/W1963603865","https://openalex.org/W1964217313","https://openalex.org/W1964841369","https://openalex.org/W1965135809","https://openalex.org/W1983688597","https://openalex.org/W2010831960","https://openalex.org/W2017458992","https://openalex.org/W2025740330","https://openalex.org/W2030301242","https://openalex.org/W2048366382","https://openalex.org/W2061555322","https://openalex.org/W2065143046","https://openalex.org/W2068504903","https://openalex.org/W2070237659","https://openalex.org/W2080152031","https://openalex.org/W2083920169","https://openalex.org/W2086899389","https://openalex.org/W2121858968","https://openalex.org/W2126388071","https://openalex.org/W2135397849","https://openalex.org/W2141166715","https://openalex.org/W2144095981","https://openalex.org/W2144658061","https://openalex.org/W2149185709","https://openalex.org/W2157856009","https://openalex.org/W2170773413","https://openalex.org/W2327535499","https://openalex.org/W2593231312","https://openalex.org/W2802048935","https://openalex.org/W2962988880","https://openalex.org/W2995517530","https://openalex.org/W4240640633","https://openalex.org/W6771546305"],"related_works":["https://openalex.org/W2530415252","https://openalex.org/W1964217313","https://openalex.org/W4238444439","https://openalex.org/W4298366880","https://openalex.org/W2149185709","https://openalex.org/W2070237659","https://openalex.org/W2327535499","https://openalex.org/W2481556475","https://openalex.org/W2785052952","https://openalex.org/W2196190612"],"abstract_inverted_index":{"BACKGROUND:":[0],"Tenofovir":[1,26],"disoproxil":[2],"fumarate":[3],"(TDF)":[4],"can":[5],"cause":[6],"renal":[7,265,324],"and":[8,72,95,139,167,206,208,245,290,328],"bone":[9,326],"toxicity,":[10],"which":[11],"is":[12,29],"associated":[13],"with":[14,34,121,132,222,309],"high":[15],"plasma":[16,39],"tenofovir":[17,32,40],"concentrations":[18],"in":[19,38,59,106,179,218,229,235,258,297,323],"antiretroviral":[20],"treatment":[21,303],"of":[22,48,70,124,190,269,292,304],"HIV-1":[23,133,305],"infected":[24],"patients.":[25,63,334],"alafenamide":[27],"(TAF)":[28],"a":[30,35,49,54,107,122],"novel":[31],"prodrug":[33],"90%":[36],"reduction":[37],"concentrations.":[41],"We":[42,65,113],"aimed":[43],"to":[44,80,197,216],"assess":[45],"the":[46,60,73,136,140,184,223,226,255,270,312,317,332],"non-inferiority":[47],"TAF-containing":[50,137,227,256,293,318],"combination":[51],"regimen":[52,58],"versus":[53],"TDF-containing":[55,141,224,271,313],"fixed-dose":[56,298],"single-tablet":[57,299],"antiretroviral-treatment-naive,":[61],"HIV-1-infected":[62],"METHODS:":[64],"searched":[66],"PubMed,":[67],"Embase,":[68],"Web":[69],"Science,":[71],"Cochrane":[74],"Trial":[75],"Registry,":[76],"from":[77,90],"January":[78],"2001":[79],"July":[81],"2019,":[82],"using":[83,110],"relevant":[84],"keywords.":[85],"Available":[86],"data":[87],"were":[88,129,204,212,295],"extracted":[89],"eligible":[91,116],"randomized":[92,117],"trials":[93,119],"(RCTs)":[94,120],"pooled":[96],"as":[97,214],"risk":[98],"ratios":[99],"(RRs)":[100],"or":[101],"standardized":[102],"mean":[103],"differences":[104],"(SMDs)":[105],"meta-analysis":[108,285],"model":[109],"Stata/SE.":[111],"RESULTS:":[112],"included":[114],"seven":[115],"controlled":[118],"total":[123],"6269":[125],"participants.":[126],"Patients":[127],"who":[128],"antiretroviral-naive":[130],"adults":[131],"on":[134,316],"both":[135,236],"regimens":[138,142,228,257,272,294,300,319],"had":[143,175,231,260,320],"similar":[144,213],"virologic":[145],"suppression":[146],"effects":[147],"(RR,":[148,238,247],"1.02;":[149],"95%":[150,194,277],"CI,":[151,195,278],"1.00-1.04;":[152],"p":[153,199,242,251,280],">":[154],"0.05)":[155,244],"at":[156],"week":[157,162,168],"24":[158],"(93.99%":[159],"vs.":[160,165,171],"94.20%),":[161],"48":[163,188,274],"(90.71%":[164],"89.54%),":[166],"96":[169],"(86.16%":[170],"84.80%).":[172],"Both":[173,202],"groups":[174],"no":[176],"significant":[177,321],"improvements":[178],"CD4":[180],"cell":[181],"count":[182],"for":[183,264,301,331],"naive":[185,333],"patients":[186,230,259,315],"during":[187],"weeks":[189,275],"therapy":[191],"(SMD,":[192],"0.09;":[193],"0.01":[196],"0.16;":[198],"<":[200,243,252,281],"0.05).":[201,253,282],"treatments":[203],"safe":[205],"well-tolerated,":[207],"most":[209],"adverse":[210],"events":[211,266],"mild":[215],"moderate":[217],"severity.":[219],"Moreover,":[220],"compared":[221,308],"regimens,":[225,314],"significantly":[232,261],"smaller":[233],"reductions":[234],"hip":[237],"0.33;":[239],"95CI,":[240,249],"0.29-0.39;":[241],"spine":[246],"0.58;":[248],"0.51-0.65;":[250],"Additionally,":[254],"fewer":[262],"increases":[263],"than":[267],"those":[268,310],"through":[273],"(0.31;":[276],"0.18-0.55;":[279],"CONCLUSIONS:":[283],"Our":[284],"indicated":[286],"that":[287],"efficacy,":[288],"safety,":[289],"tolerability":[291],"non-inferior":[296],"initial":[302],"infection.":[306],"Furthermore,":[307],"receiving":[311],"advantages":[322],"function,":[325],"parameters,":[327],"lipid":[329],"profile":[330]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3003135182","counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-01-30T00:00:00"}
